Development and Characterization of Guizotia abyssinica (L.f.) Cass. Ethosomes

Abstract

In order to minimize issues with stability, toxicity, and poor bioavailability, various novel drug delivery systems are currently preferred. Formulation of herbal drugs is emerging as a promising tool for the treatment of many diseases with less toxic effects, better therapeutic effect, and patient compliance. Herbal extract is being used to develop NDDS such phytosomes, ethosomes, herbal transdermal patches, and nanoparticles. In the current study, ethanolic extract of Guizotia abyssinica (L.f.) Cass Fowers' ethosomes is being created. We assessed the developing ethosomes. The results show that the EEGAF formulation code GAF-5 has the highest EE, which is 92.89.